|
Announcements
BIOMET 3i SELECTS CLINIVATION'S GLOBAL MARKET CLEARANCE SERVICES.
Leading manufacturer of dental implants, abutments, and related products selects clinivation's Global Market Clearance Services to position their operations for continued growth and successful expansion.
Natick, MA, August 13, 2008
- clinivation, Inc. announced today that BIOMET 3i has selected the clinivation's Global Market Clearance Services
"BIOMET 3i is a world leader in the development, manufacture, and distribution of oral reconstructive products, and we are pleased that they have selected clinivation's Global Market Clearance Services to position their operations for continued growth and successful expansion," said Richard Morroney, R.A.C., C.Q.A., clinivation's Vice President of Quality and Regulatory Solutions.
About clinivation's Global Market Clearance Services
Clinivation's Global Market Clearance services leverage our excellence in market clearance and many years of focused, successful experience in developing and supporting thousands of medtech market clearance applications in all of the major and emerging world markets. Our many years of successful experience spans from comprehensive initiation, support, and execution of the most complex Class III PMA programs to focused global market clearance initiatives.
About BIOMET 3i
Headquartered in Palm Beach Gardens, Florida, with operations throughout the world, BIOMET 3i is one of the world's leading companies in the oral reconstruction market. BIOMET 3i offers one of implant dentistry's most comprehensive lines of implants and abutments, augmented by a growing line of site preparation and regenerative products. BIOMET 3i pioneered the development of biologically driven implants, winning worldwide acclaim for the microtextured surface and superior clinical success rates of the OSSEOTITE ® Implant.
Of equal importance, since its inception in 1987, BIOMET 3i has brought the same innovation, high standards, and comprehensive approach to customer service, practice and laboratory support and education.
For more information, please visit www.biomet3i.com
About clinivation, Inc.
Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.
Used in over 100,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.
The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.
Our core brands include the clinivation Global® xi market clearance platform, clinivation WorldView® on-demand regulatory intelligence, and clinivation Clinical Suite® and clinivation Registry Suite® electronic data capture and clinical data management software.
Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.
Visit clinivation online at www.clinivation.com
For further information:
For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560. |
